1.610USD+6.62%Mkt Cap: 4.76M USDP/E: —Last update: 2026-05-22
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap4.76M USD
Enterprise Value172.16K USD
Revenue (TTM)14.82K USD
Gross Profit14.82K USD
Net Income (TTM)-6.50M USD
Revenue/Share0.0080 USD
Last Price1.610 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.04
PEG—
EV/EBITDA-0.03
EV/Revenue11.61
P/S301.44
P/B0.40
EPS (TTM)-3.37
EPS (Forward)-0.25
52W Range
0.97009% of range7.910
52W High7.910 USD
52W Low0.9700 USD
Profitability
Gross Margin100.00%
Oper. Margin-41159.55%
EBITDA Margin0.00%
Profit Margin-43832.49%
ROE-93.19%
ROA-83.67%
Growth
Revenue Growth-21.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.73M USD
CapEx (TTM)419.31K USD
FCF Margin-25698.10%
FCF Yield-79.96%
Net Debt-4.42M USD
Net Debt/EBITDA0.73
Balance Sheet
Debt/Equity0.10
Current Ratio9.79
Quick Ratio8.46
Book Value/Sh3.819 USD
Cash/Share1.727 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.96M
Float2.83M
Insiders8.31%
Institutions9.34%
Short Interest
Short Ratio0.7d
Short % Float1.58%
Short % Out.1.58%
Shares Short46.81K
Short (prev mo.)22.26K
Technical
SMA 501.972 (-18.3%)
SMA 2003.032 (-46.9%)
Beta2.26
S&P 52W Chg28.31%
Avg Vol (30d)67.25K
Avg Vol (10d)69.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—